Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases

Clinical trial NCT02360215 · COMPLETED

Trial details

NCT number: NCT02360215
Sponsor: NRG Oncology
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cognitive Impairment Metastatic Malignant Neoplasm in the Brain Solid Neoplasm

Start date: 2015-07-01
Primary completion: 2018-04-30
Enrollment: 518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.